1-5 of 5
Veerle M.H. Coupé
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers

Available to Purchase
Gabrielle Jongeneel, Marjolein J.E. Greuter, Natalia Kunst, Felice N. van Erning, Miriam Koopman, Jan P. Medema, Louis Vermeulen, Jan N.M. Ijzermans, Geraldine R. Vink, Cornelis J.A. Punt, Veerle M.H. Coupé
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2021) 30 (9): 1726–1734.
https://doi.org/10.1158/1055-9965.EPI-21-0078
Published: 01 September 2021
View articletitled, Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers
Open the PDF for Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers in another window
Includes: Supplementary data
Journal Articles

Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States

Available to Purchase
Natalia Kunst, Fernando Alarid-Escudero, Eline Aas, Veerle M.H. Coupé, Deborah Schrag, Karen M. Kuntz
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2020) 29 (12): 2710–2718.
https://doi.org/10.1158/1055-9965.EPI-20-0490
Published: 01 December 2020
View articletitled, Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States
Open the PDF for Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States in another window
Includes: Supplementary data
Journal Articles

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia

Free
Jie-Bin Lew, D. James B. St John, Finlay A. Macrae, Jon D. Emery, Hooi C. Ee, Mark A. Jenkins, Emily He, Paul Grogan, Michael Caruana, Marjolein J.E. Greuter, Veerle M.H. Coupé, Karen Canfell
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2018) 27 (12): 1450–1461.
https://doi.org/10.1158/1055-9965.EPI-18-0128
Published: 03 December 2018
View articletitled, Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia
Open the PDF for Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia in another window
Includes: Supplementary data
Journal Articles

Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality—Model-Based Exploration of the Serrated Pathway

Free
Marjolein J.E. Greuter, Erhan Demirel, Jie-Bin Lew, Johannes Berkhof, Xiang-Ming Xu, Karen Canfell, Evelien Dekker, Gerrit A. Meijer, Veerle M.H. Coupé
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2016) 25 (1): 135–144.
https://doi.org/10.1158/1055-9965.EPI-15-0592
Published: 12 January 2016
View articletitled, Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality—Model-Based Exploration of the Serrated Pathway
Open the PDF for Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality—Model-Based Exploration of the Serrated Pathway in another window
Journal Articles

Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal Cancers

Free
Jochim S. Terhaar sive Droste, Frank A. Oort, René W.M. van der Hulst, Henk A. van Heukelem, Ruud J.L.F. Loffeld, Sietze T. van Turenhout, Ilhame Ben Larbi, Shannon L. Kanis, Maarten Neerincx, Mirre Räkers, Veerle M.H. Coupé, Anneke A. Bouman, Gerrit A. Meijer, Chris J.J. Mulder
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2011) 20 (2): 272–280.
https://doi.org/10.1158/1055-9965.EPI-10-0848
Published: 06 February 2011
View articletitled, Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal Cancers
Open the PDF for Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal Cancers in another window